The Beijing Angle Closure Progression Study

Recruiting Observational Study
Angle-Closure Glaucoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo. No Study Drug Researchers observe your health over time — no experimental treatment is given.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
40 – 75
Sex
Any
Study type
Observational
Participants needed
825 (estimated)
Sponsor
Peking University People's Hospital · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The Beijing angle closure progression study (BAPS) aims to explore the 5-year incidence of PACS progressing to PAC or PACG and to determine the possible risk factors of disease progression, which may provide the evidence for choosing the accurate strategies in the management of PACS.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * "Static" gonioscopy identifying 6 or more clock hours of angle circumference in which the posterior (usually pigmented) trabecular meshwork cannot be seen in both eyes with no peripheral anterior synechiae, and normal intraocular pressure (IOP), optic nerve and visual field. *…
Contacts

Huijuan Wu, M.D. Ph.D.

8613811293109

dr_wuhuijuan@126.com

CONTACT